An Act respecting a national framework on sickle cell disease
Topics
Ask Agora about this page
Ask about this bill or session. Agora will automatically use the visible page context.
At a glance
The bill aims to establish a national framework for sickle cell disease. It calls for collaboration between the federal government, provinces, and territories to enhance awareness, screening, and treatment of the disease. The framework will include strategies to support affected individuals and their families.
Detailed summary
Bill S-201 primarily aims to create a national framework on sickle cell disease, a genetic disorder affecting the shape of red blood cells. This framework seeks to harmonize efforts across Canada to improve the quality of life for affected individuals.
Key provisions of the bill include measures to increase public and healthcare professional awareness of sickle cell disease. It also promotes early screening and access to effective treatments. The national framework will include guidelines for disease management and healthcare professional training.
The bill does not directly amend other laws but relies on collaboration between different levels of government for implementation. This includes sharing information and resources between the federal government, provinces, and territories.
Individuals with sickle cell disease and their families are the primary entities affected by this bill. Additionally, healthcare professionals and public health organizations will be involved in implementing the strategies proposed by the national framework.
Legislative progress
Senate
- First readingMay 28, 2025
- Second readingJun 12, 2025
- Consideration in committeeOct 23, 2025
- Third readingNov 18, 2025
House of Commons
- First readingDec 11, 2025
- Second readingJun 16, 2026
- Consideration in committeeUpcoming
- Report stageUpcoming
- Third readingUpcoming
- Royal assentUpcoming
Recent debates
Official source: ourcommons.ca